cisapride has been researched along with Central Nervous System Diseases in 4 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Five studies reported the use of cisapride and tegaserod in people with spinal cord injuries or Parkinson's disease." | 4.90 | Management of faecal incontinence and constipation in adults with central neurological diseases. ( Cody, JD; Coggrave, M; Norton, C, 2014) |
| "Five studies reported the use of cisapride and tegaserod in people with spinal cord injuries or Parkinson's disease." | 4.89 | Management of faecal incontinence and constipation in adults with central neurological diseases. ( Coggrave, M; Norton, C, 2013) |
| " Cisapride does not seem to have clinically useful effects in people with spinal cord injuries (three trials)." | 4.83 | Management of faecal incontinence and constipation in adults with central neurological diseases. ( Coggrave, M; Norton, C; Wiesel, PH, 2006) |
| " Cisapride does not seem to have clinically useful effects in people with spinal cord injuries (two trials)." | 4.81 | Management of faecal incontinence and constipation in adults with central neurological diseases. ( Brazzelli, M; Norton, C; Wiesel, PH, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coggrave, M | 3 |
| Norton, C | 4 |
| Cody, JD | 1 |
| Wiesel, PH | 2 |
| Brazzelli, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neurogenic Bowel Dysfunction: Evaluation of the Effects of Osteopathic Manipulative Treatment in People With Central Nervous System Injury[NCT04127617] | 70 participants (Anticipated) | Interventional | 2019-10-28 | Recruiting | |||
| Automatic Colon-specific Massage With MOWOOT Medical Device to Treat Chronic Constipation in Adults[NCT04262752] | 100 participants (Actual) | Interventional | 2018-01-11 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for cisapride and Central Nervous System Diseases
| Article | Year |
|---|---|
Management of faecal incontinence and constipation in adults with central neurological diseases.
Topics: Adult; Central Nervous System Diseases; Cisapride; Constipation; Fecal Incontinence; Gastrointestina | 2013 |
Management of faecal incontinence and constipation in adults with central neurological diseases.
Topics: Central Nervous System Diseases; Cisapride; Constipation; Fecal Incontinence; Gastrointestinal Agent | 2014 |
Management of faecal incontinence and constipation in adults with central neurological diseases.
Topics: Central Nervous System Diseases; Cisapride; Constipation; Fecal Incontinence; Gastrointestinal Agent | 2006 |
Management of faecal incontinence and constipation in adults with central neurological diseases.
Topics: Central Nervous System Diseases; Cisapride; Constipation; Fecal Incontinence; Gastrointestinal Agent | 2001 |